Following completion of the reverse stock split, private placement, and merger, there are approximately 60.6 million shares ...

The combined company will operate as Jade Biosciences, Inc., with its shares expected to begin trading on the Nasdaq Capital Market on April 29, 2025, under the ticker symbol “JBIO.” ...

including immunoglobulin A nephropathy or IgA nephropathy. The company has license agreements with Amgen, Inc., and Eli Lilly and Company. Anthera Pharmaceuticals, Inc. was founded in 2004 and is ...

Seemingly a footnote in Eala’s story was Iga Świątek, defending champion in Madrid, the winner of four French Opens, and already a contender to be the greatest women’s clay-court player of ...

As Iga Świątek prepares for a challenging draw at the upcoming Mutua Madrid Open, her coach Wim Fissette has shed light on the team's focus on improving a key component of her game: the serve.

One of the most highly anticipated matchups in the second round of the Madrid Open is the rematch between WTA World No. 2 Iga Swiatek and Alexandra Eala. Last month, Eala upset Swiatek in the ...

Iga Swiatek revealed that she was focused on herself and not on Alexandra Eala's 'hype' after avoiding a second upset against the Philippines' star. Eala defeated Swiatek at the Miami Open and led ...

World No. 1 Iga Swiatek in her press conference at the Madrid Open, shared important insights into the balance between personal autonomy and external pressures that professional tennis players ...

It was not always pretty, but a win is a win for Iga Swiatek. Especially when she can avenge her loss to Alexandra Eala from last month's Miami Open. On Thursday, Swiatek defeated Eala in a hard ...

European Commission converts conditional approval of FILSPARI (sparsentan) into standard marketing authorization for the treatment of IgA Nephropathy (IgAN) Decision follows positive recommendation ...